🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

Based on TikTok, the service has removed violative content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at home.

After minutes of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts display dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.